Assay of creatine kinase isoenzyme MB in serum with time-resolved immunofluorometry

Clin Chem. 1990 Sep;36(9):1679-83.

Abstract

We describe the first time-resolved immunofluorometric assay for creatine kinase (EC 2.7.3.2) isoenzyme MB (CK-MB) in serum. The assay is based on the formation of the complex: solid-phase anti-CK-MB-CK-MB-biotinylated anti-CK-BB-streptavidin-BCPDA-Eu3+, where anti-CK-MB and anti-CK-BB are monoclonal antibodies against the CK isoenzymes MB and BB, respectively, and BCPDA is the europium chelator 4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid. The solid-phase complex is fluorescent and is measured on the dry solid-phase (microtiter well) in a specially designed time-resolved fluorometer that uses laser excitation. The assay requires 25 microL of serum and is not affected by the presence of either CK-MM (up to 5000 micrograms/L) or CK-BB (up to 1000 micrograms/L) in the sample. Precision and accuracy indices for the assay were satisfactory.

Publication types

  • Comparative Study

MeSH terms

  • Antibodies, Monoclonal
  • Creatine Kinase / blood*
  • Europium
  • Fluoroimmunoassay
  • Humans
  • Isoenzymes

Substances

  • Antibodies, Monoclonal
  • Isoenzymes
  • Europium
  • Creatine Kinase